XECHEM INTERNATIONAL INC
SC 13D, 1997-08-21
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: OCUREST LABORATORIES INC, 10QSB, 1997-08-21
Next: FPA MEDICAL MANAGEMENT INC, S-8, 1997-08-21



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No.  )


                           XECHEM INTERNATIONAL, INC.
                           --------------------------
                                (Name of issuer)


                    COMMON STOCK, $.00001 PAR VALUE PER SHARE
                    -----------------------------------------
                         (Title of class of securities)


                                   983895-10-3
                                   -----------
                                 (CUSIP number)


                              Jai Gupta, President
                                EER Systems, Inc.
                              10289 Aerospace Road
                            Seabrook, Maryland 20706
                                 (301) 306-7838

                                 With a copy to:
                            Michael D. Schwamm, Esq.
                  Warshaw Burstein Cohen Schlesinger & Kuh, LLP
                                555 Fifth Avenue
                            New York, New York 10017
                                 (212) 984-7832
             -------------------------------------------------------
(Name,  address and telephone number of person authorized to receive notices and
communications)

                                 AUGUST 1, 1997
                          ---------------------------
             (Date of event which requires filing of this statement)




If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

Note: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule  13d-1(a) for other  parties to whom copies are to be
sent.



                                Page 1 of 8 Pages
<PAGE>

CUSIP No. 983895-10-3

- --------------------------------------------------------------------------------
1.  Names of Reporting Persons.  S.S. or I.R.S.                EER Systems, Inc.
    Identification Nos. of Above Persons


- --------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                     (a) [ ]
    (See Instructions)                                                   (b) [ ]

- --------------------------------------------------------------------------------
3.  SEC Use Only

- --------------------------------------------------------------------------------
4.  Source of Funds (See Instructions)                                        WC


- --------------------------------------------------------------------------------
5.  Check if Disclosure of Legal Proceedings is
    Required Pursuant to Items 2(d) or 2(e)                                  [ ]

- --------------------------------------------------------------------------------
6.  Citizenship or Place of Organization                                Virginia


- --------------------------------------------------------------------------------
    Number of Shares 7.  Sole Voting Power                                     0
     Beneficially    -----------------------------------------------------------
    Owned by Each    8.  Shared Voting Power (see Item 4 below)       20,000,000
     Reporting       -----------------------------------------------------------
    Person With      9.  Sole Dispositive Power                                0
                     -----------------------------------------------------------
                     10. Shared Dispositive Power (see Item 4 below)  20,000,000

- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially
    Owned by Each Reporting Person                                    20,000,000


- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes
    Certain Shares (See Instructions)                                        [ ]


- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)                     16.9%


- --------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)                               CO


- --------------------------------------------------------------------------------


                                Page 2 of 8 Pages
<PAGE>

CUSIP No. 983895-10-3

- --------------------------------------------------------------------------------
1.  Names of Reporting Persons.  S.S. or I.R.S.                     Jai N. Gupta
    Identification Nos. of Above Persons


- --------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                     (a) [ ]
    (See Instructions)                                                   (b) [ ]


- --------------------------------------------------------------------------------
3.  SEC Use Only


- --------------------------------------------------------------------------------
4.  Source of Funds (See Instructions)                                        00


- --------------------------------------------------------------------------------
5.  Check if Disclosure of Legal Proceedings is
    Required Pursuant to Items 2(d) or 2(e)                                  [ ]


- --------------------------------------------------------------------------------
6.  Citizenship or Place of Organization                           United States


- --------------------------------------------------------------------------------
    Number of Shares 7.  Sole Voting Power                                     0
     Beneficially    -----------------------------------------------------------
    Owned by Each    8.  Shared Voting Power (see Item 4 below)       20,000,000
     Reporting       -----------------------------------------------------------
    Person With      9.  Sole Dispositive Power                                0
                     -----------------------------------------------------------
                     10. Shared Dispositive Power (see Item 4 below)  20,000,000

- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially
    Owned by Each Reporting Person                                    20,000,000


- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes
    Certain Shares (See Instructions)                                        [ ]


- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)                     16.9%


- --------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)                               IN


- --------------------------------------------------------------------------------
                                Page 3 of 8 Pages
<PAGE>

CUSIP No. 983895-10-3

- --------------------------------------------------------------------------------
1.  Names of Reporting Persons.  S.S. or I.R.S.                     Shashi Gupta
    Identification Nos. of Above Persons


- --------------------------------------------------------------------------------
2.  Check the Appropriate Box if a Member of a Group                     (a) [ ]
    (See Instructions)                                                   (b) [ ]


- --------------------------------------------------------------------------------
3.  SEC Use Only


- --------------------------------------------------------------------------------
4.  Source of Funds (See Instructions)                                        00


- --------------------------------------------------------------------------------
5.  Check if Disclosure of Legal Proceedings is
    Required Pursuant to Items 2(d) or 2(e)                                  [ ]


- --------------------------------------------------------------------------------
6.  Citizenship or Place of Organization                           United States


- --------------------------------------------------------------------------------
    Number of Shares  7.  Sole Voting Power                                    0
     Beneficially     ----------------------------------------------------------
    Owned by Each     8.  Shared Voting Power (see Item 4 below)      20,000,000
     Reporting        ----------------------------------------------------------
    Person With       9.  Sole Dispositive Power                               0
                      ----------------------------------------------------------
                      10. Shared Dispositive Power (see Item 4 below) 20,000,000

- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially
    Owned by Each Reporting Person                                    20,000,000


- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes
    Certain Shares (See Instructions)                                        [ ]


- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)                     16.9%


- --------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)                               IN

- --------------------------------------------------------------------------------


                                Page 4 of 8 Pages
<PAGE>

ITEM 1.  SECURITY AND ISSUER.
         -------------------

         This Schedule 13D relates to the common  stock,  $0.00001 par value per
share  (the  "Common  Stock"),  of  Xechem   International,   Inc.,  a  Delaware
corporation (the "Company").  The principal executive offices of the Company are
located at 100 Jersey Avenue,  Building B, Suite 310, New Brunswick,  New Jersey
08901.

ITEM 2.  IDENTITY AND BACKGROUND.
         -----------------------

         This  Schedule 13D is jointly  filed by EER  Systems,  Inc., a Virginia
corporation  ("EER"),  Dr. Jai Gupta and Shashi Gupta  (hereinafter  referred to
individually  as  a  "Reporting  Person"  and  collectively  as  the  "Reporting
Persons").

         The business address for each of the Reporting  Persons is EER Systems,
Inc., 10289 Aerospace Road, Seabrook, Maryland 20706.

         EER is a corporation  organized  under the laws of the  Commonwealth of
Virginia, and is engaged in system development and integration, including launch
vehicles.  Dr. Gupta and Mrs. Gupta are each citizens of the United States.  Jai
Gupta  and Mrs.  Gupta  are  principally  employed  as the  President  and Chief
Executive  Officer,  respectively,  of EER. Dr. Gupta and Mrs. Gupta are husband
and wife and are the only executive officers and stockholders of EER.

         During the last five years,  none of the Reporting Persons has been (i)
convicted in a criminal  proceeding  (excluding  traffic  violations  or similar
misdemeanors)  or  (ii)  a  party  to  a  civil  proceeding  of  a  judicial  or
administrative body of competent jurisdiction and as a result of such proceeding
was or is  subject  to a  judgment,  decree  or  final  order  enjoining  future
violations  of, or prohibiting  or mandating  activities  subject to, Federal or
state securities laws or finding any violation with respect to such laws.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
         -------------------------------------------------

         On August 1, 1997, EER purchased  20,000,000  shares of Common Stock at
$.05 per share, for a total of $1,000,000.  The source of funds for the purchase
was the internal working capital of EER.

         No part of the  purchase  price  was  represented  by  funds  or  other
consideration  borrowed or  otherwise  obtained  for the  purpose of  acquiring,
holding, trading or voting the Common Stock.

ITEM 4.  PURPOSE OF TRANSACTION
         ----------------------

         On November 18, 1996,  the Company,  Mr. David Blech and Dr.  Ramesh C.
Pandey  entered into a Stock  Purchase  Agreement  (the  "Purchase  Agreement").
Pursuant to an Assignment and Assumption Agreement (the "Assignment Agreement"),
dated August 1, 1997, between EER and Mr. Blech, EER acquired  20,000,000 of the
shares of Common Stock subject to the Purchase Agreement. In accordance with the
terms of the  Assignment  Agreement,  EER has  become a party to a  Stockholders
Agreement (the  "Stockholders  Agreement"),  dated November 18, 1996,  among the
Company,  Mr. Blech and Dr. Pandey,  pursuant to which,  among other things, EER
has agreed to vote all shares of Common Stock  beneficially  owned by it for the
election of Dr.  Pandey as a director of the Company and to use its best efforts
to cause Dr.  Pandey to be named as Chairman of the Board,  President  and Chief
Executive Officer of the Company.

         In addition,  pursuant to the terms of a Voting Agreement,  dated as of
August 1, 1997,  among Dr.  Pandey,  EER and Dr.  Gupta,  EER and Dr. Gupta have
agreed to vote all shares of capital stock of the Company  beneficially owned by
them, now or hereafter, in the manner directed by Dr. Pandey, on all


                                Page 5 of 8 Pages
<PAGE>

matters  which may be  presented  to  stockholders,  except to the  extent  such
agreement  conflicts with their  obligations  under the Stockholders  Agreement.
Pursuant to the Voting  Agreement,  EER and Dr. Gupta have granted Dr.  Pandey a
proxy to vote such shares in accordance with the Voting Agreement.

         As a result of the  Stockholders  Agreement and Voting  Agreement,  the
Reporting  Persons  may be  deemed a member  of a "group"  for the  purposes  of
Section  13(d) under the  Securities  Exchange  Act of 1934.  The filing of this
Schedule 13D shall not be deemed an admission  by any of the  Reporting  Persons
that it is a member of such group.

         The Reporting  Persons  consider the  acquisition  and ownership of the
Common Stock to be an investment.

         Subject to the  availability of Common Stock at prices deemed favorable
by the  Reporting  Persons,  the  Reporting  Persons'  liquidity,  the financial
condition  and results of operations  of the Company,  and general  economic and
market  conditions  prevailing at the time,  the Reporting  Persons  reserve the
right to, and may in the future,  purchase  additional Common Stock from time to
time  in  the  open  market,  through  privately  negotiated  transactions,   or
otherwise.

         Except as set forth above, none of the Reporting Persons have any plans
or  proposals  which  relate to or would  result in (a) the  acquisition  by any
person of additional  securities of the Company or the disposition of securities
of the Company, (b) an extraordinary  corporate  transaction,  such as a merger,
reorganization, or liquidation,  involving the Company or any of its securities,
(c) a sale or transfer of a material  amount of the assets of the Company or any
of its  subsidiaries,  (d) any  change  in the  present  board of  directors  or
management of the Company, including any plans or proposals to change the number
or term of  directors or to fill any  existing  vacancies on the board;  (e) any
material change in the present capitalization or dividend policy of the Company,
(f) any other material change in the Company's business or corporate  structure,
(g) changes in the  Company's  charter,  bylaws,  or  instruments  corresponding
thereto or other  actions  which may impede  the  acquisition  of control of the
Company by any person,  (h) causing a class of the  securities of the Company to
be delisted from a national  securities exchange or to cease to be authorized to
be  quoted  in  an  inter-dealer  quotation  system  of  a  registered  national
securities association, (i) a class of equity securities of the Company becoming
eligible for  termination of  registration  pursuant to Section  12(g)(4) of the
Exchange Act, or (j) any action similar to any of those enumerated above.

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.
         ------------------------------------

         As of the  date of this  Schedule  13D,  EER owns  beneficially  and of
record an aggregate of 20,000,000 shares of Common Stock,  representing 16.9% of
the issued and  outstanding  shares of Common  Stock  (based on an  aggregate of
118,327,839  shares of Common Stock  outstanding  as of August 1, 1997).  As the
sole executive officers and stockholders of EER, Dr. Gupta and Mrs. Gupta may be
deemed to have shared  voting and  dispositive  power with respect to all of the
shares of Common Stock owned of record by EER.

         Except as set forth  above,  the  Reporting  Persons  do not share with
others the power to vote or to direct the vote of, or the power to dispose of or
to direct the disposition of, any other shares of Common Stock.

         Except as set forth above, the Reporting  Persons have not effected any
transactions  in the Common Stock during the 60 days  preceding the date of this
Schedule 13D.


                                Page 6 of 8 Pages
<PAGE>

ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR
         RELATIONSHIPS, WITH RESPECT TO SECURITIES OF THE
         ISSUER.
         ------------------------------------------------

         Except for the Purchase Agreement,  the Stockholders  Agreement and the
Voting  Agreement  which are  described in Item 4 above,  none of the  Reporting
Persons are a party to any contract, arrangement,  understanding or relationship
(legal or  otherwise)  with any person  with  respect to any  securities  of the
Company, including, but not limited to, any agreement concerning (i) transfer or
voting of any  securities  of the  Company,  (ii)  finder's  fees,  (iii)  joint
venture, (iv) loan or option arrangements, (v) puts or calls, (vi) guarantees of
profits,  (vii)  divisions  of  profits  or  losses,  or  (viii)  the  giving or
withholding of proxies.

ITEM 7.   MATERIAL TO BE FILED AS EXHIBITS.
          --------------------------------

         1.  Joint  Filing  Agreement.  dated as of  August 8,  1997,  among Jai
Gupta, Shashi Gupta and EER Systems, Inc.

         2.  Stock Purchase  Agreement,  dated  November 18, 1996,  among Xechem
International  Inc.,  David Blech and Ramesh C. Pandey,  including  Stockholders
Agreement, dated November 18, 1996, among Xechem International Inc., David Blech
and Ramesh C.  Pandey  (Incorporated  by  reference  to  Exhibits 2 and 4 to the
Schedule  13D filed by David Blech and The Edward  Blech  Trust on November  29,
1996).

         3.  Voting  Agreement,  dated as of August  1,  1997,  among  Ramesh C.
Pandey, EER Systems,  Inc. and Jai Gupta (Incorporated by reference to Exhibit 2
to the Schedule 13D filed by Ramesh C. Pandey on or about August 7, 1997).

                                    * * * * *

                                    SIGNATURE
                                    ---------

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Dated:  August 8, 1997



                                            /s/ JAI GUPTA
                                            ----------------------------
                                                Jai Gupta


                                            /s/ SHASHI GUPTA
                                            ----------------------------
                                                Shashi Gupta


                                            EER SYSTEMS. INC.


                                            By: /s/ JAI GUPTA
                                                ------------------------
                                                    Jai Gupta, President


                                Page 7 of 8 Pages


                                                                       EXHIBIT 1

                             JOINT FILING AGREEMENT


         Pursuant to Rule  13d-1(f)(1)(iii)  of the  Securities  Exchange Act of
1934,  each of the  undersigned  agrees that a single joint Schedule 13D and any
amendments  thereto  may be  filed on  behalf  of each of the  undersigned  with
respect to securities held by each of them in Xechem, Inc.

Dated:  August 8, 1997



                                            /s/ JAI GUPTA
                                            ----------------------------
                                                Jai Gupta


                                            /s/ SHASHI GUPTA
                                            ----------------------------
                                                Shashi Gupta


                                            EER SYSTEMS. INC.


                                            By: /s/ JAI GUPTA
                                                ------------------------
                                                    Jai Gupta, President


                                Page 8 of 8 Pages


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission